Real-World Use of Sotrovimab for Pre-Emptive Treatment in High-Risk Hospitalized COVID-19 Patients: An Observational Cross-Sectional Study
Ong et al., Antibiotics, doi:10.3390/antibiotics11030345
https://c19early.org/ong2.html